The TIMP2 Membrane Type 1 Metalloproteinase “Receptor” Regulates the Concentration and Efficient Activation of Progelatinase A-Reference-Cited by-同舟云学术

The TIMP2 Membrane Type 1 Metalloproteinase “Receptor” Regulates the Concentration and Efficient Activation of Progelatinase A

Published:1998-01 Issue:2 Volume:273 Page:871-880
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Butler Georgina S.,Butler Michael J.,Atkinson Susan J.,Will Horst,Tamura Tatsuya,van Westrum Steven Schade,Crabbe Thomas,Clements John,d'Ortho Marie-Pia,Murphy Gillian

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference42 articles.

1. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family.

2. Autolytic Activation of Recombinant Human 72 Kilodalton Type IV Collagenase

3. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties

4. The Activation of Human Type IV Collagenase Proenzyme

5. Reciprocated matrix metalloproteinase activation: A process performed by interstitial collagenase and progelatinase A

Cited by 522 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the bidirectional role of MMP9: A key player in kidney injury;Cellular Signalling;2024-10

2. Everolimus exerts anticancer effects through inhibiting the interaction of matrix metalloproteinase-7 with syndecan-2 in colon cancer cells;American Journal of Physiology-Cell Physiology;2024-04-01

3. Differentiation States of Phenotypic Transition of Melanoma Cells Are Revealed by 3D Cell Cultures;Cells;2024-01-17

4. Tissue inhibitors of metalloproteinases are proteolytic targets of matrix metalloproteinase 9;Matrix Biology;2023-11

5. A New Therapeutic Option for Reversing the Deficits in Dark Adaptation Associated with Age-Related Macular Degeneration (AMD);Macular Diseases - An Update [Working Title];2023-10-19